Results 51 to 60 of about 39,460 (147)

Utility of serological markers in inflammatory bowel diseases: Gadget or magic? [PDF]

, 2007
The panel of serologic markers for inflammatory bowel diseases (IBD) is rapidly expanding. Although anti-Saccharomyces cerevisiae antibodies (ASCA) and atypical perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) remain the most widely ...
Altorjay, István, Lakatos, Péter László, Norman, G. L., Papp, Mária   +3 more
core   +1 more source

Drug therapy of primary biliary diseases: classical and modern strategies [PDF]

, 2013
Definition: Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are both cholestatic liver diseases. A common feature of these disorders is the accumulation of bile acids in the liver and blood, presumably because of decreased ...
Leuschner, Ulrich, Schlichting, Julia
core  

Systematic review with meta‐analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation

Alimentary Pharmacology and Therapeutics, 2019
After liver transplantation primary sclerosing cholangitis (PSC), the condition returns in the transplanted liver in a subset of patients (recurrent primary sclerosing cholangitis, rPSC).
I. Steenstraten, K. Sebib Korkmaz, P. Trivedi, A. Inderson, B. van Hoek, Mar Rodriguez Gírondo, P. J. Maljaars   +6 more
semanticscholar   +1 more source

Intrahepatic cholangiocarcinoma: review and update [PDF]

, 2018
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies that could develop at any level from the biliary tree. CCA is currently classified into intrahepatic (iCCA), perihilar and distal on the basis of its anatomical location.
Alvaro, Domenico, Bragazzi, Maria Consiglia, Cardinale, Vincenzo, Carpino, Guido, Di Matteo, Sabina, Gaudio, Eugenio, Nevi, Lorenzo, Overi, Diletta   +7 more
core   +1 more source

An Overview on Primary Sclerosing Cholangitis

Journal of Clinical Medicine, 2020
Primary sclerosing cholangitis is a progressive liver disease characterized by chronic inflammation leading to liver fibrosis and cirrhosis. Even though the exact pathogenesis is still unclear, a combination of autoimmune, environmental, and ischemic ...
C. Vlăduț, M. Ciocîrlan, Dana Bilous, V. Șandru, Mădălina Stan-Ilie, N. Panic, G. Becheanu, M. Jinga, R. Costache, D. Costache, M. Diculescu   +10 more
semanticscholar   +1 more source

Pyoderma Gangrenosum Associated with Sclerosing Cholangitis, Type 1 Diabetes Mellitus and Ulcerative Colitis [PDF]

, 2001
We describe the case of a 22-year-old black female with type 1 diabetes mellitus diagnosed when she was 12 years old. She first presented (March 1994) with pustules and ulcerations on the upper and lower limbs, trunk and scalp at the age 17.
A Morbey, Basler, Bastin, Bretagne, Cairns, Callen, Callen, F Assis Pacheco, F Fonseca, F Pereira, Greenberger, Greenstein, Hickman, Hohenleutner, Holt, Kaplan, Lim, M Goreti Catorze, Magro, O'Loughlin, Olsson, Philpott, Powell, Schwaegerle, Shelley, Stathers, Thornton, Warren, Wolf   +28 more
core   +1 more source

Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Alimentary Pharmacology and Therapeutics, 2020
Primary sclerosing cholangitis (PSC) is associated with progressive liver disease and cholangiocarcinoma. Although risk stratification is crucial for making clinical decisions, it is hindered by a scarcity of proven prognostic markers.
E. Wunsch, G. Norman, M. Milkiewicz, M. Krawczyk, C. Bentow, Z. Shums, M. Mahler, S. Lopens, D. Reinhold, A. Franke, C. Schramm, D. Roggenbuck, P. Milkiewicz   +12 more
semanticscholar   +1 more source

A New Mutation Causing Progressive Familiar Intrahepatic Cholestasis Type 3 in Association with Autoimmune Hepatitis [PDF]

, 2017
Background: Some patients exhibit features of both autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC). Similarly, patients with progressive familial intrahepatic cholestasis type 3 (PFIC3) may share histological features with PSC.
Oliveira, Hugo M., Pereira, Cláudia, Pessegueiro-Miranda, Helena, Pinto-Basto, Jorge, Santos-Silva, Ermelinda, Vizcaíno, José R.   +5 more
core   +3 more sources

Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis

Alimentary Pharmacology and Therapeutics, 2019
Single‐centre studies reported alterations of faecal microbiota in patients with primary sclerosing cholangitis (PSC). As regional factors may affect microbial communities, it is unclear if a microbial signature of PSC exists across different ...
M. Rühlemann, T. Liwinski, Femke-Anouska Heinsen, C. Bang, R. Zenouzi, M. Kummen, L. Thingholm, Marie Tempel, W. Lieb, T. Karlsen, A. Lohse, J. Hov, G. Denk, F. Lammert, M. Krawczyk, C. Schramm, A. Franke   +16 more
semanticscholar   +1 more source

Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient [PDF]

, 2013
Autoimmune liver disease management goals are primarily slowing disease progression and symptomatic treatment. There are few options for curative medical management other than transplant for a spectrum of autoimmune liver disease that encompasses ...
Abhyankar, Anita, Bonder, Alan, Tapper, Elliot   +2 more
core   +2 more sources